Evidence for a Pan-Neurodegenerative Disease Response in Huntington's and Parkinson's Disease Expression Profiles

被引:27
|
作者
Labadorf, Adam [1 ,2 ]
Choi, Seung H. [3 ]
Myers, Richard H. [1 ,2 ,3 ]
机构
[1] Boston Univ, Bioinformat Program, Boston, MA 02215 USA
[2] Boston Univ, Dept Neurol, Boston, MA 02215 USA
[3] Boston Univ, Sch Publ Hlth, Biostat, Boston, MA USA
来源
基金
美国国家卫生研究院;
关键词
Huntington disease; Parkinson disease; mRNA-seq; neuroinflammation; bioinformatics and computational biology; neurodegenerative diseases; immune system; NF-KAPPA-B; MITOCHONDRIAL-DNA DAMAGE; ELEMENT-BINDING PROTEIN; GENE-EXPRESSION; MOUSE MODEL; PATHOLOGY; STRESS; REDD1; PHOSPHORYLATION; RTP801/REDD1;
D O I
10.3389/fnmol.2017.00430
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Huntington's and Parkinson's Diseases (HD and PD) are neurodegenerative disorders that share some pathological features but are disparate in others. For example, while both diseases are marked by aberrant protein aggregation in the brain, the specific proteins that aggregate and types of neurons affected differ. A better understanding of the molecular similarities and differences between these two diseases may lead to a more complete mechanistic picture of both the individual diseases and the neurodegenerative process in general. We sought to characterize the common transcriptional signature of HD and PD as well as genes uniquely implicated in each of these diseases using mRNA-Seq data from post mortem human brains in comparison to neuropathologically normal controls. The enriched biological pathways implicated by HD differentially expressed genes show remarkable consistency with those for PD differentially expressed genes and implicate the common biological processes of neuroinflammation, apoptosis, transcriptional dysregulation, and neuron-associated functions. Comparison of the differentially expressed (DE) genes highlights a set of consistently altered genes that span both diseases. In particular, processes involving nuclear factor kappa-light-chain-enhancer of activated B cells (NFkB) and transcription factor cAMP response element-binding protein (CREB) are the most prominent among the genes common to HD and PD. When the combined HD and PD data are compared to controls, relatively few additional biological processes emerge as significantly enriched, suggesting that most pathways are independently seen within each disorder. Despite showing comparable numbers of DE genes, DE genes unique to HD are enriched in far more coherent biological processes than the DE genes unique to PD, suggesting that PD may represent a more heterogeneous disorder. The complexity of the biological processes implicated by this analysis provides impetus for the development of better experimental models to validate the results.
引用
收藏
页数:12
相关论文
共 50 条
  • [41] Saccadic latencies as a biomarker for Huntington's and Parkinson's disease
    Antoniades, C. A.
    Xu, Z.
    Carpenter, R. H. S.
    Barker, R. A.
    MOVEMENT DISORDERS, 2008, 23 (01) : S188 - S188
  • [42] Huntington's disease - Exploiting expression
    Bates, GP
    NATURE, 2001, 413 (6857) : 691 - +
  • [43] Transcriptomic profiles in Parkinson's disease
    Kurvits, Lille
    Lattekivi, Freddy
    Reimann, Ene
    Kadastik-Eerme, Liis
    Kasterpalu, Kristjan M.
    Koks, Sulev
    Taba, Pille
    Planken, Anu
    EXPERIMENTAL BIOLOGY AND MEDICINE, 2021, 246 (05) : 584 - 595
  • [44] The gestational environment and Parkinson's disease: Evidence for neurodevelopmental origins of a neurodegenerative disorder
    Barlow, Brian K.
    Cory-Slechta, Deborah A.
    Richfield, Eric K.
    Thiruchelvam, Mona
    REPRODUCTIVE TOXICOLOGY, 2007, 23 (03) : 457 - 470
  • [45] The Metabolic Basis for Nervous System Dysfunction in Alzheimer's Disease, Parkinson's Disease, and Huntington's Disease
    Maiese, Kenneth
    CURRENT NEUROVASCULAR RESEARCH, 2023, 20 (03) : 314 - 333
  • [46] Cognition, function and awareness of disease impact in early Parkinson's and Huntington's disease
    Julio, Filipa
    Ribeiro, Maria J.
    Morgadinho, Ana
    Sousa, Mario
    van Asselen, Marieke
    Simoes, Mario R.
    Castelo-Branco, Miguel
    Januario, Cristina
    DISABILITY AND REHABILITATION, 2022, 44 (06) : 921 - 939
  • [47] Porcine xenografts in parkinson's disease and Huntington's disease patients: Preliminary results
    Fink, JS
    Schumacher, JM
    Ellias, SL
    Palmer, EP
    Saint-Hilaire, M
    Shannon, K
    Penn, R
    Starr, P
    VanHorne, C
    Kott, HS
    Dempsey, PK
    Fischman, AJ
    Raineri, R
    Manhart, C
    Dinsmore, J
    Isacson, O
    CELL TRANSPLANTATION, 2000, 9 (02) : 273 - 278
  • [48] Deleterious effects of minocycline in animal models of Parkinson's disease and Huntington's disease
    Diguet, E
    Fernagut, PO
    Wei, X
    Du, YS
    Rouland, R
    Gross, C
    Bezard, E
    Tison, F
    EUROPEAN JOURNAL OF NEUROSCIENCE, 2004, 19 (12) : 3266 - 3276
  • [49] Genetic analysis of Parkinson's disease, torsion dystonia and Huntington's disease in Belarus
    Yacuts, O. A.
    Mosse, K. A.
    Pleshko, I. V.
    Likhachev, S. A.
    MOVEMENT DISORDERS, 2013, 28 : S395 - S395
  • [50] Inhibitory Control During Smooth Pursuit in Parkinson's Disease and Huntington's Disease
    Henderson, Tracy
    Georgiou-Karistianis, Nellie
    White, Owen
    Millist, Lynette
    Williams, David R.
    Churchyard, Andrew
    Fielding, Joanne
    MOVEMENT DISORDERS, 2011, 26 (10) : 1893 - 1899